Therefore, we hypothesized that the inflammatory effects of advanced coronary artery disease may be, at least in part, mediated through low Gas6 levels as well as reduced Gas6/Axl signaling, and consequently activated systemic immunity. The gene discussed is GAS6; the disease is coronary artery disorder.